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Abstract
Background: Antenatal care is an important public health priority. Women from socially disadvantaged, and
culturally and linguistically diverse groups often have difficulties with accessing antenatal care and report more
negative experiences with care. Although group antenatal care has been shown in some settings to be effective for
improving women’s experiences of care and for improving other maternal as well as newborn health outcomes,
these outcomes have not been rigorously assessed in the UK. A pilot trial will be conducted to determine the
feasibility of, and optimum methods for, testing the effectiveness of group antenatal care in an NHS setting serving
populations with high levels of social deprivation and cultural, linguistic and ethnic diversity. Outcomes will inform
the protocol for a future full trial.
Methods: This protocol outlines an individual-level randomised controlled external pilot trial with integrated
process and economic evaluations. The two trial arms will be group care and standard antenatal care. The trial will
involve the recruitment of 72 pregnant women across three maternity services within one large NHS Acute Trust.
Baseline, outcomes and economic data will be collected via questionnaires completed by the participants at three
time points, with the final scheduled for 4 months postnatal. Routine maternity service data will also be collected
for outcomes assessment and economic evaluation purposes. Stakeholder interviews will provide insights into the
acceptability of research and intervention processes, including the use of interpreters to support women who do
not speak English. Pre-agreed criteria have been selected to guide the decision about whether or not to progress
to a full trial.
Discussion: This pilot trial will determine if it is appropriate to proceed to a full trial of group antenatal care in this
setting. If progression is supported, the pilot will provide authoritative high-quality evidence to inform the design
and conduct of a trial in this important area that holds significant potential to influence maternity care, outcomes
and experience.
Trial registration: ISRCTN ISRCTN66925258. Registered 03 April 2017. Retrospectively registered.
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Background
Antenatal care is an important public health priority as
it has the potential to impact positively on women’s
health during pregnancy and upon the subsequent life
course of women and their children. Women from so-
cially disadvantaged and ethnic minority groups often
have difficulties with accessing antenatal care [1] and re-
port more negative experiences with care, despite having
potentially complex social and medical needs [2]. Lack
of engagement with antenatal care has been associated
with adverse pregnancy outcomes including low birth-
weight, neonatal mortality and maternal mortality [3–5].
Group antenatal care combines conventional aspects
of antenatal assessment with information sharing, in-
cluding group discussion and learning, and the oppor-
tunity for social support for pregnant women. It is
facilitated by health professionals (often midwives) for
small groups of women with similar estimated due dates
(and potentially their partners). To date, group-based
models have been successfully implemented in a number
of countries worldwide, including Australia [6], Sweden
[7] and the USA [8]. Antenatal care configured in this
way has been shown to increase women’s satisfaction
with care and has improved health and safety outcomes
such as pre-term birth and low birthweight [8–10].
Antenatal care for women in groups addresses multiple
factors that have been found to be associated with
women’s negative experiences of antenatal care [11–14].
As each appointment lasts for approximately 2 h (com-
pared with approximately 15–20 min for a standard ante-
natal care appointment) and is facilitated by the same
health professionals at each session, this model increases
the amount of time that a pregnant woman spends with
caregivers, e.g. midwives [6, 15], and enables continuity of
carer [16]. It also provides for social support amongst
group members, who, in our setting, may have become
resident quite recently and/or may have migrated from
abroad, where, for these and other reasons (e.g. financial
constraints, limited English language ability), they may not
have optimal existing support networks. Helping to ad-
dress some of the main problems vulnerable and culturally
and/or linguistically diverse women experience with
standard, fragmented care, continuity of carer has been
found to be beneficial, delivering enhanced communica-
tion and interpersonal rapport [17–19].
Furthermore, providing antenatal care within small
groups promotes discussion and potentially, more effective
learning for and amongst women, rather than solely relying
on a health professional as the source of ‘expert advice’. It
is also pertinent to note that many women living within the
target areas do not currently have access to traditional ante-
natal education classes for various reasons. It is expected
that this new approach will empower women, giving them
more of ‘a voice’, enhancing informed decision making, and
enabling them to tailor antenatal care more closely to their
own needs. Significant benefits have been associated with
such empowerment. If women feel that they have more au-
tonomy and choice, this has been shown to increase their
sense of control around birthing, and subsequently, this has
the potential to increase their satisfaction with the birthing
experience. Whether women experience birthing as a posi-
tive and affirming life event or as a traumatic, negative ex-
perience has the potential to affect their well-being and that
of their children for the future life course [20–24]. The ap-
proach also encourages women to engage in more
self-monitoring, with the aim of increasing knowledge and
confidence; again, these factors have been shown to be sig-
nificant in increasing the likelihood of a positive birth ex-
perience [25–28].
Although group antenatal care has been shown in
other settings to be effective for improving women’s
experiences of care and for improving other maternal
as well as newborn health outcomes, these outcomes
have not been formally assessed in the UK. A recent
systematic review of group antenatal care concluded
that more high-quality studies of its effectiveness are
needed to establish whether positive findings are
widely applicable [29]. These health improvements are
in line with national and local aspirations for redu-
cing inequalities and improving the health and
well-being of women and children [23]. We are there-
fore proposing to evaluate robustly the effectiveness
and cost-effectiveness of group-based antenatal care
in enhancing women’s experience of antenatal care,
increasing its relevance and value to women, and im-
proving outcomes for mother and baby, particularly
amongst women from ethnically, culturally and lin-
guistically diverse and disadvantaged areas who are
more likely to experience worse outcomes [30, 31].
This pilot trial is important to assess the best
methods for conducting this proposed randomised
controlled trial of this model of group antenatal care
in the UK. Following best practice for pilot trials of
complex interventions, pre-agreed progression criteria
have been identified to inform the decision about
whether to proceed, to proceed with amendments or
not to proceed to a full trial (see Table 1) [32]. This
paper relates to the pilot trial protocol version 2
(22.7.16) and adheres to the SPIRIT checklist report-
ing guidelines (Additional file 1).
Methods/design
Pilot trial aims
This pilot trial aims to determine the optimum methods
for testing the effectiveness of a bespoke model of group
antenatal care, called ‘Pregnancy Circles’, in a UK NHS
setting serving populations with high levels of social
deprivation and cultural, linguistic and ethnic diversity.
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It will inform the protocol for a full randomised con-
trolled trial of the Pregnancy Circles model. The pilot
trial will be undertaken to include an assessment of:
1. Methods of recruitment, recruitment rates, and
reasons for declining participation;
2. Retention in groups and reasons for drop out;
3. Data collection for outcome assessment;
4. Approaches to language support for intervention
and research purposes.
An additional aim will be the further development and
refinement of the Pregnancy Circles model of group
antenatal care for culturally, linguistically, ethnically and
socio-economically diverse communities. This will in-
clude determining the extent of the linguistic diversity
that can be incorporated in a single Pregnancy Circle.
The pilot trial will also aim to determine the suitability
of our proposed primary outcome measure (spontaneous
vaginal birth) and to develop a composite measure of a
‘healthy birth’ for the economic evaluation.
Intervention
Following an extensive feasibility study, Pregnancy Cir-
cles are being implemented by a London NHS Trust as
part of its service development. Initially, this was on a
small-scale basis (four test groups in the feasibility work,
followed by the three groups that form the focus of this
pilot trial). Each Pregnancy Circle will consist of be-
tween 8 and 12 pregnant women who have estimated
delivery dates within the same approximate 2- to 4-week
period. The women who consent to participation in the
study will be randomly assigned to one of two trial arms.
One arm will receive standard antenatal care, whereas
the other will receive all of their usual midwife-led ante-
natal care within a Pregnancy Circle. Any necessary ap-
pointments for consultant or specialist care will be
carried out as per the usual care pathways outside of
(and in addition to) the Circle.
Those women randomised to the group, antenatal
care will start attending the ‘Pregnancy Circle’ for the
first time at the routine midwife appointment (approxi-
mately 16 weeks of pregnancy) that follows their ante-
natal booking appointment (this usually takes place
between 8 and 12 weeks of pregnancy). Subsequently,
the women will continue to attend the Circle according
to the normal antenatal care schedule. Any woman who
chooses to discontinue her care in a group during preg-
nancy will transfer to the conventional care pathway.
Any woman who does not attend the first Circle will be
contacted by the facilitating midwives to ascertain the
reasons for this. If non-attendance is due to pregnancy
loss, they will be referred, by the facilitating midwives,
to sources of ongoing support, such as their GP, as
appropriate.
Each Pregnancy Circle group session will be facilitated
by two midwives supplemented with bilingual health ad-
vocates or other support staff as appropriate. The same
two midwives will facilitate all the sessions for a Preg-
nancy Circle, and each woman will have one of these
midwives as their lead midwife. Women participating in
the ‘Pregnancy Circle’ who are having their first child
will receive the same number of antenatal appointments
as women receiving standard care. Women having sub-
sequent children will be offered the same number of
antenatal appointments as women having their first
child, therefore receiving two additional appointments to
the standard model for women having subsequent
children. All women attending the ‘Pregnancy Circle’
will receive standard postnatal care but will also be in-
vited to a postnatal reunion session held approximately
1 month after the last antenatal appointment (40 weeks
of pregnancy). A local health visitor will co-facilitate this
reunion postnatal session with the midwives. Women in
the control group will continue to have standard postna-
tal care and then standard health visitor care.
There will be a total of eight antenatal group sessions
each of which will last for approximately 2 h. The first
Table 1 Progression criteria to full trial
Green light Amber light Red light
Recruitment—numbers of
available women in each
catchment
Within each catchment area,
60+ pregnant women with
appropriate due dates
Within each catchment area, 40–59
pregnant women with appropriate
due dates
Within the catchment area, less
than 40 pregnant women with
appropriate due dates
Recruitment—percentage who
consent to randomisation
More than 40% who are eligible
consent to randomisation
20–40% who are eligible consent to
randomisation
Less than 20% who are eligible
agree to randomisation
Uptake of group care model 8 or more of the 12 randomised
take up the groups
6–7 of the 12 randomised take up
the group
Fewer than 6 of the 12 randomised
take up the group
Retention in groups* 5 remain in the group for 6+ sessions 4–5 remain in the group for
6+ sessions
Fewer than 4 women remain in the
group for 6+ sessions
Follow-up response
rate—self-complete
outcomes questionnaire(s)
75% or greater response to follow-up 40–74% response to follow-up Less than 40% response to
follow-up
*Allowing for preterm births and moving out of the NHS Trust usual catchment area
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part of each session will involve ‘self-care activities’ (e.g.
women will be taught how and encouraged to take an
active part in their care by testing their own urine, tak-
ing their own/each other’s blood pressure and writing
the results in their notes). Following these checks, the
sessions will involve short one-to-one sessions with one
of the midwife facilitators for individual health checks
(e.g. abdominal palpation) whilst the rest of the group
has a group discussion facilitated by the second midwife.
Any concerns regarding a group member’s blood pres-
sure or scan or test results, or any individual psycho-
logical or social issues, can be addressed during the
individual health check or at the end of a session by a
woman’s lead midwife, whilst the other midwife con-
tinues facilitating the group. The content of group dis-
cussions will be woman-led, supplemented as
appropriate by the facilitating midwives to ensure that
essential topics are covered, as per national and local
guidelines. As with usual care, women will be referred to
other specialist services for routine and additional ap-
pointments, blood tests and scans as appropriate. The
postnatal session will use a similar approach and format,
but with a focus on maternal postnatal well-being and
the well-being of the baby and infant feeding support.
Midwife and health visitor facilitators will be docu-
menting the appointment in the same way they usually
would. During the first group session, the facilitating
midwives will develop ground rules of confidentiality,
asking the participants to respect each other’s privacy
and confidentiality regarding what is shared within the
group. The views of the group on how and when part-
ners are involved in the sessions will be ascertained.
Pregnancy Circles model is a ‘bespoke’ model of ante-
natal care, designed to be flexible in order to allow the
midwives and women to adapt it to suit local need—this
may include the inclusion of external speakers, involving
student midwives or other appropriate observers, or
making adaptations for women with language or other
needs.
Study setting
The pilot trial will be carried out within the mater-
nity services of an inner London acute NHS Trust.
This Trust provides services primarily to residents of
three London boroughs. One Pregnancy Circle (i.e.
one group of women who have their antenatal ap-
pointments together) will be run within each of these
three boroughs by midwives from the local service.
The exact area within each borough in which the
Pregnancy Circles will be run will largely be deter-
mined by practical issues, with decisions being made
in consultation with service managers. The Circles
will run in the usual working area of the midwives
who facilitate them.
Trial design
A UK-based external pilot randomised controlled trial
will involve two parallel arms: one receiving a group
model of antenatal care (Pregnancy Circles) and the
other receiving usual care. It will not be possible for par-
ticipants or maternity staff to be blinded to allocation.
Researchers conducting process evaluation observations
and interviews will also be unblinded. Data informatics
staff supplying outcomes information from electronic re-
cords and those conducting the statistical analysis will
be blinded to the intervention allocation.
Inclusion criteria
Eligibility will be assessed by a researcher or research
midwife within the antenatal booking clinic. Those who
will be eligible include:
 Women who are currently pregnant and registering
(or registered) for antenatal care at the participating
NHS Trust maternity service
 Primiparous and multiparous women
 All pregnant women, regardless of the risk category
applied to their pregnancy (both ‘low’ and ‘high’ risk
pregnancies included)
 Women who live within the working areas of the
local midwife group facilitators and have an
estimated delivery date that fits with those of a
proposed group
The pilot will test groups with a limited diversity of
languages spoken and groups with greater linguistic di-
versity (e.g. with one to three additional languages other
than English). Thus, the recruitment for different Preg-
nancy Circles will have different inclusion criteria with
respect to particular languages spoken.
Exclusion criteria
The following are the exclusion criteria:
 Non-pregnant women
 Women registered for antenatal care at other NHS
Trusts
 Pregnant women who live outside the local target
area
 Pregnant women whose estimated delivery dates do
not fit with those of a proposed group
 Pregnant women who, at the time of antenatal
booking, will likely not be able to participate at the
proposed group start date and/or throughout the
entire series
 Pregnant women who are under 16 years of age at
the time of recruitment
 Pregnant women with a documented learning
disability
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 Pregnant women who speak a language that is not a
target language for the group being recruited at the
time of their potential recruitment
Sample size
The study will aim to recruit 24 participants from each
of the three maternity units within the participating
NHS Trust making a combined total of 72 women. Half
of the recruited women in each area (up to 12 women)
will be randomised to take part in the ‘Pregnancy Cir-
cles’ and half to receive standard antenatal care. This
sample will not be powered to show differences between
the trial arms on outcomes. Rather, the sample size has
been determined to allow us to test the assumptions
used in the sample size calculations for a full trial. This
sample size will allow recruitment to take place in the
three geographical areas in the NHS Trust where the
Pregnancy Circles will take place, to allow us to test re-
cruitment rates and to assess whether this differs by
area. It will also allow us to explore uptake and retention
rates to see whether our assumptions about the loss to
follow-up are appropriate.
Recruitment of participants
Potential participants will be recruited from women at-
tending their first midwife appointment to register with
the NHS Trust maternity services (the ‘booking appoint-
ment’, which usually takes place when women are be-
tween 8 and 13 weeks pregnant). The research team will
work with the antenatal booking clerks in each area to
identify women who fit the inclusion criteria prior to the
booking appointment. The participant information leaf-
let (PIL) about the REACH Pregnancy Circles study and
an introductory letter will be included with the mailed
booking appointment confirmation letter to these
women.
Recruitment and consent will be carried out by
REACH researchers and research midwives employed by
the NHS Trust. Once attending their booking appoint-
ment, all women who fit the inclusion criteria will be
approached by a researcher in the waiting room. An
additional copy of the PIL will be provided. A verbal ex-
planation of the Pregnancy Circles, the study and the
concept of randomisation will also be given by the re-
cruiter, and women will have the opportunity to ask
questions, using interpreting services where appropriate.
Women who decline to participate in the pilot trial
will be invited to take part in a brief (5-min) interview
on their understanding of group antenatal care and their
reasons for declining to participate. If they provide
verbal consent to this 5-min interview, an anonymous
proforma will be used to record their responses as well
as basic demographic information and the date and
venue of the clinic. These data will inform recruitment
procedures for the potential future full trial. The inter-
view will be with a researcher/research midwife at the
time they decline to take part. It will be made very clear
to women that their views will be used to inform efforts
to recruit to future groups and that they are not being
asked to justify or change their decision.
If a woman is unsure about whether she wishes to par-
ticipate in the trial, she will be able to contact the re-
searcher after the booking visit. She will be given a copy
of the consent form and baseline questionnaire to take
away to be completed at home if she decides to partici-
pate. Stamped addressed envelopes will also be provided.
She will be asked if she is happy to give her telephone
number/email address to the researcher so that a re-
minder contact can be made to clarify whether she is in-
terested in participating. If a woman does not wish to
give this contact information, she will have the option to
telephone the research team using the number given on
the PIL.
Women who choose to participate in the ‘Pregnancy
Circles’ will be asked to sign a consent form and to fill
in a self-completed baseline questionnaire. Language
support, as described below, will be offered for the com-
pletion of both, if required. It will be explained in writ-
ing and verbally that they can withdraw at any time if
they so wish.
Language support
The study population is extremely diverse in terms of
languages spoken. We will use the pilot trial to test out
the feasibility and acceptability of different forms of lan-
guage support. The principal forms of language support
we plan to use in the trial are (1) bilingual health advo-
cates employed by the NHS Trust1, (2) language line (a
telephone interpreting service) and (3) bilingual advo-
cates from an external agency.
We are particularly focussing on working in partner-
ship with the health advocacy service within the NHS
Trust which will be funded to provide services for the
trial. This will include providing advocates to work
alongside a researcher supporting recruitment and con-
sent, telephone follow-up and questionnaire completion
in clinic, community and home settings. Advocates will
also work one-to-one with women in the Pregnancy
Circles. We aim to provide training sessions about the
research for the Trust’s health advocates as well as the
staff who book advocates and attend meetings to facili-
tate joint working. We expect there to be occasions
when an appropriate advocate is not available from the
service, including when an eligible woman presents who
speaks a language that is unusual for the area. In these
instances, language line will be used for recruitment,
and an external health advocate will be found to support
further involvement.
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Randomisation
Participants will be allocated to Pregnancy Circles or
usual care in a one-to-one ratio. Block randomisation
will be carried out by a statistician in the Pragmatic
Clinical Trials Unit (PCTU), independent of the trial.
Randomisation will be stratified by the estimated deliv-
ery date and the location of the Pregnancy Circle. The
research team will notify the woman verbally and in
writing of her allocation and working with booking
clinic staff will confirm either her next appointment date
and time (for women allocated to the control group) or
the full list of dates, times and venue for the Pregnancy
Circles (intervention group).
Pilot trial feasibility outcomes
Data will be collected on recruitment; uptake of, and re-
tention in, the Pregnancy Circle groups; and outcomes
data collection rates. Figure 1 highlights the assessments
that will be completed by participants, as per the SPIRIT
Statement [33].
The different rates achieved in the pilot will enable es-
timates to be made for a full trial. Additionally, they will
inform decisions about changes that need to be imple-
mented and the appropriateness of progression to such a
trial; this process will be undertaken in conjunction with
the Programme Steering Committee (see Table 1). ‘Red
light’ rates will halt the progression, unless suitable solu-
tions can be implemented.
(i) Recruitment figures will be kept for each antenatal
booking clinic session attended by the research
midwives via a proforma, regarding numbers of
women eligible, number approached, number who
declined and number who consented. No
identifying information will be recorded.
Approaches used for language support will be
recorded.
(ii) Uptake and retention to the intervention will be
derived from records kept by the midwives who are
facilitating the Pregnancy Circles, who will record
attendance at each group using a paper proforma,
STUDY PERIOD
Enrolment Allocation Post-allocation (months) Close-out
TIMEPOINT -t1 0 1 6 7 10 tx
ENROLMENT:
Eligibility screen X
Informed consent X
Allocation X
INTERVENTIONS:
Pregnancy Circle
Standard care
ASSESSMENTS:
Recruitment rate
X
Uptake of intervention 
rate
X
Completion of 
intervention rate
X
Completion rates 
outcomes questionnaires
X X X
Completeness of routine 
maternity data X
Acceptability, satisfaction
and feasibility 
X X X
Fig. 1 Schedule of enrolment, interventions and assessments. SPIRIT diagram for REACH Pregnancy Circles pilot study
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which they will pass on to the research team. The
research team will transfer this information to a
password-protected electronic database and replace
names with study IDs. The paper proformas will
then be destroyed. Midwives will have a protocol to
follow for women who choose not to participate in
the Circle, at any point through the intervention, to
ensure that all women receive antenatal care.
(iii)Questionnaire completion rates will be used to assess
the potential burden of data collection for
participants. We will explore completion rates at
each of the two follow-up points and whether each
measure within the questionnaire is completed in a
way that provides useable data. We will explore the
questionnaire completion rates for women who
required a bilingual advocate, to provide further
information about the appropriateness of our
research tools. Additionally, this will be assessed
through open questions during one-to-one interviews
with participants (see the “Process data—views about
trial methods and the intervention” section below).
More detail is provided on the questionnaires in the
“Participant outcomes data collection” section below.
Process data—views about trial methods and the
intervention
Process data will also be collected from participants and
key stakeholders to assess the feasibility of the proposed
methods for the full trial of ‘Pregnancy Circles’. The aim
of this data collection will be to help explain the reasons
behind any challenges with recruitment, uptake, reten-
tion and outcomes data collection and to provide solu-
tions for improvement. This data will be collected
through process questions added at the end of the out-
comes questionnaires (see Table 2) and one-to-one inter-
views with a small sample of women and staff.
The process evaluation will include the following
components:
a) Five-minute interview and anonymous proforma for
women who decline to take part in the study, as
described in the ‘Recruitment of patients’ section
above.
b) Interviews with Pregnancy Circle participants
At the final antenatal group session, participants in the
Pregnancy Circles will be offered the opportunity to have
a one-to-one semi-structured interview after their baby
has been born. This will last 30–60 min and will be con-
ducted either face-to-face or via the telephone according
to participant preference. A purposeful sample of ap-
proximately 20 participants will be interviewed, at a time
(probably around 6 weeks postnatal) and location of
their choice. Women may choose to have their partners
and/or children with them during the interview. Women
who have suffered an adverse neonatal outcome (neo-
natal death, admission to the neonatal unit) will not be
interviewed unless they specifically request it. The facili-
tating midwives will confirm whether women who had
previously consented to the interview can be contacted
postnatally. The purpose of the interviews will be to ex-
plore their experiences and satisfaction with this model
of antenatal care and their perceptions of its effects, as
well as their views on recruitment, randomisation and
data collection methods. The views and experiences of
women who received language support will also be
sought.
c) Interviews with women who leave the ‘Pregnancy
Circles’
Women who discontinue with a group during preg-
nancy will be invited to participate in an interview (up
to 30 min, in person or by telephone depending on pref-
erence). Women who suffered pregnancy loss will not be
approached for these interviews. The purpose of the in-
terviews will be to explore the reasons the woman has
decided to leave the group, and if relevant, explore how
the group failed to match the women’s expectations, in-
cluding the content, convenience and conduct of the
sessions. The interviews will elicit suggestions for future
groups and explore women’s views about randomisation
to this kind of care.
d) Interviews with facilitating midwives and other staff
involved with ‘Pregnancy Circles’
In order to provide context to data collected from
women, a purposeful sample of midwives and other rele-
vant staff at the participating NHS Trust will be offered
the opportunity to take part in a brief (up to 30 min)
interview about their perceptions of the recruitment and
randomisation procedures, the data collection methods
(e.g. timing) and issues relating to delivery of and reten-
tion in the Pregnancy Circles. Interviews with midwives
will include questions pertaining to potential contamin-
ation of usual care by the introduction of Pregnancy Cir-
cles care.
Information about the process evaluation participants
(name, contact details, demographic details) will be
stored on a participant information database on the se-
cure server at City University London. Study ID num-
bers will be used on collected data to ensure anonymity.
Signed consent forms for process data collection will be
stored separately in a locked filing cabinet in the office
of the research team at UEL, which requires an access
code to enter. The interviews will be transcribed verba-
tim, and the confidentiality of personal data will be
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ensured through the use of anonymisation and pseudo-
nymisation techniques. All audio recordings and tran-
scripts will be stored securely in a locked filing cabinet,
in a locked office, that only members of the research
team will have access to. Transcribers will be bound by a
confidentiality agreement.
All qualitative interview data will be entered into the
data analysis package NVivo, which will be used to man-
age and code data. The data will be subjected to the-
matic framework analysis. Codes will be applied line by
line to transcripts, which will identify key themes and
how these inter-relate in order to develop an analytical
framework.
Participant outcomes data collection
Participant outcomes data in a prospective full trial will be
collected via two routes: questionnaires completed by the
participants and routine maternity service data collected
from the Trust. The task in the pilot, as explained, is to as-
sess the completion rates and also to determine the
optimum processes for collecting useable outcomes data.
Outcomes questionnaires general overview
The questionnaires will be administered as online and
hard copies, with participants able to select their pre-
ferred mode. The research team will use a database to
track the sending out and return of hard copies. To fa-
cilitate online surveys, an electronic participant-recorded
outcome tool, provided by the PCTU, will be used. This
will have the facility to email participants a link to ques-
tionnaires. All women will be offered a £10 voucher for
each of the three questionnaires they complete. These
will be handed to women who complete their question-
naire in the presence of a researcher and posted to
women who submit their questionnaire without a re-
searcher being present.
The questionnaires will be identified only with study
ID number. The hard copies of the questionnaires will
be stored in a locked filing cabinet in a pin code access-
ible office for the duration of the study. Data will be en-
tered onto a database developed and maintained by the
PCTU. For hard copy questionnaires, research team staff
will do full double data entry for the primary outcome
and double data entry on a 10% sample for other out-
comes. Depending on identified error rates, the propor-
tion of data double entered may be increased.
The participants’ questionnaires will be completed at
three time points: baseline (8–12 weeks pregnant), first
follow-up questionnaire (35 weeks pregnant) and second
follow-up questionnaire (approximately 4 months after
the baby is born). The baseline questionnaire will in-
clude demographic questions, a limited number of out-
come measures and some questions relating to service
preferences. The follow-up questionnaires will include
outcome measures and some process questions relating
to randomisation, attendance at antenatal care and pref-
erences for providing outcomes information, see Table 2
for details on the questionnaires.
Baseline questionnaire
The baseline questionnaire will be provided by the re-
searcher, as a hard copy or electronically on a tablet
computer, for immediate completion following recruit-
ment in the antenatal clinic. Completion will be prior to
trial arm allocation being revealed to the women in
order that knowledge of the type of care they will receive
does not influence their responses. Women who cannot
complete immediately, or want time to consider partici-
pation in the trial, will be given a hard copy (and an ad-
dressed/postage paid envelope) to post back or they can
be provided with a link to the online survey to complete
at home. These women will be informed of their trial
arm status once the questionnaire has been received. If
questionnaires that are taken away are not returned after
2 weeks, a telephone call will be made to offer comple-
tion over the phone with a researcher. For those women
who do not speak English or who have limited literacy,
the researchers will offer to make home/community
visits to administer the questionnaires accompanied by a
bilingual health advocate where required.
Feedback from our patient and public involvement (PPI)
representatives on the draft baseline questionnaire sug-
gested that this should be as short and simple as possible
to be acceptable to the diverse community in the study.
The validated measures within the questionnaire were
perceived as particularly challenging and off-putting to
potential participants. Two versions of the questionnaire
will therefore be used to test acceptability—one, a short-
ened version of the other. A randomly allocated schedule
of distribution of the two versions will be developed by an
independent statistician. Approximately half the recruited
women will be given the longer version and half the
shorter, via sealed and numbered envelopes. Recruiters
will be unaware of the allocation. Acceptability to partici-
pants of the different versions will be assessed by relative
completion rates. The statistical implications of not having
certain data at baseline will also be reviewed.
Follow-up outcomes questionnaires
For the intervention group, the first follow-up question-
naire will be provided at the completion of the Pregnancy
Circle session when women are 35 weeks pregnant. A re-
searcher will provide a hard copy or online version (on a
computer tablet) depending on a woman’s preference. In-
terpreters will be at the group, where appropriate, and will
assist with completion. Anyone who would prefer to
complete the questionnaire at home, for whatever reason,
will be supported to do so. For the control group, the
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questionnaire for the first follow-up will be completed,
with the support of a researcher, in the antenatal clinic at
a woman’s 35-week routine appointment. Where this is
not possible for any individual woman, the questionnaire
will be sent out for completion at home.
For women in both arms of the trial, the second
follow-up questionnaire will be completed at approxi-
mately 4 months postnatal. Depending on earlier specified
preferences, women will be sent hard copies to home ad-
dresses with a self-addressed envelope (SAE), and/or
women will be emailed a link to an online version.
The research team will check with antenatal clinic
staff, prior to contacting women about follow-up ques-
tionnaires, to ensure that there are no reasons (for ex-
ample the loss of a pregnancy) why a woman should not
be approached. The same pattern of reminders for
non-response to the follow-up questionnaires will be
followed as used for the baseline questionnaire (see
above). Similarly, visits will be offered with a bilingual
health advocate where there are language requirements.
Any woman who requests withdrawal from the interven-
tion following allocation will be asked if she is prepared
to continue to provide data for the study. If she is, she
will be given outcomes questionnaires as above.
Routine maternity services data
As Table 2 indicates, some participant outcomes data (in-
cluding the primary outcome data) will be assessed
through patient records, rather than from self-completed
questionnaires. Specific permission for use of patient re-
cords is part of the study consent form. The pilot trial will
use two routes to access these data: (1) through electronic
medical records and (2) through an audit of paper mater-
nity notes. The research team will check reliability and
data quality of the two versions of medical records and
will thus determine the best route for accessing the re-
quired outcomes data in a full trial. The team’s previous
work undertaken via a Programme Development Grant
suggested that some outcomes data on attendance for
antenatal care was complete in maternity notes but in-
complete in the electronic record [34].
For the data extraction from electronic patient re-
cords, the research team will develop a proforma for
the Trust Informatics team (the team responsible for
managing electronic data). We will supply them with
a list of participants’ hospital numbers and study IDs,
so no names will be required. A standard operating
procedure (SOP) will be generated, in conjunction
with the data management team at the PCTU, for the
secure transfer of data from the Trust Informatics de-
partments to the PCTU.
For the paper maternity notes, a research team mem-
ber who is blinded to the allocation to study group will
conduct an audit by extracting data manually from the
participants’ paper records within the hospital setting. A
proforma will be used that will anonymise the informa-
tion collected, using study ID numbers. The data will be
entered onto an electronic database and securely trans-
ferred to the PCTU using the SOP developed by the
PCTU data management team.
Method of analysis
Participant outcomes data will be analysed for complete-
ness and for usability in a full trial. Outcomes will be
summarised in each arm using mean and standard devi-
ation for continuous data, number and percentages for
categorical data.
Data handling
The PCTU data managers will co-ordinate the manage-
ment process for the outcomes data. Electronic systems
will be put in place that automatically manages the
process of sending out vouchers and reminders for ques-
tionnaires. It will also involve supporting the integration
of the outcomes data from participant questionnaires,
electronic maternity records and maternity audit data. A
data management plan will document the processes re-
quired to enable integration of the datasets in a manner
that maintains standardisation of data and blinding of
the statisticians. All databases and analysis files will be
stored on a secure server and accessed via a secure net-
work. Access is restricted to authorised personnel only
and via secure, password-controlled, role-based access.
Economic evaluation
In the full trial, we plan to calculate the cost-effectiveness
of Pregnancy Circles compared to control from concep-
tion until 4 months postpartum. NICE recommend that
cost-effectiveness is calculated as the cost per quality-ad-
justed life year (QALY) gained [35]. This methodology
presents significant challenges for this study. Group ante-
natal care has potential health implications and costs for
both the mother and infant, in particular as a key aim of
group antenatal care is better engagement of women with
maternity and other health care services. This could po-
tentially increase some service costs in the short term, but
also improve the health and well-being of the infant and
mother in the immediate period, and also in the medium
and longer terms. Increasing the proportion of infants vac-
cinated is the most straightforward example of improved
engagement with health care services. Although measur-
ing QALYs for the mother is possible, when and how to
start measuring QALYs from the perspective of the infant
is controversial and methodologically challenging.
In the pilot trial, the economic evaluation will explore
alternative utility measures via the participant question-
naires. Additionally, we will involve women in defining
what a ‘healthy birth’ is, so that we will be able to
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calculate the incremental cost per additional healthy
birth for group antenatal care compared to control,
using this composite measure. In the early months of
the pilot, we will work in consultation with our lay
co-investigators and with the local Maternity Services
Liaison Committees, to determine whether the suggested
questions to be used in the follow-up questionnaires to
capture women’s satisfaction with antenatal care are suf-
ficient, or whether additional ones need to be included.
Responses to antenatal care satisfaction questions plus
relevant outcomes data will be included in the compos-
ite. Initially, we will conceptualise a ‘healthy birth’ as oc-
curring if women:
1. Were largely satisfied with their care during
pregnancy
2. Felt involved in decision-making about their care
3. Had low antenatal distress
4. Did not suffer postnatal depression (within the
follow-up period)
5. Perceived that they had good levels of information
and professional support (during pregnancy, labour
and delivery)
6. Had a baby with gestational age at delivery, ≥
37 weeks.
7. Did not have a caesarean
8. Had a baby with a birthweight > 2500 g
9. Felt their care was responsive to cultural, religious/
spiritual and linguistic needs (i.e. individualised,
culturally sensitive care).
We will use the data collected during the pilot to as-
sess the validity of this composite measure and to de-
velop algorithms for how births might be classified on a
continuum from ‘healthy’ to ‘unhealthy’.
Our assumption for the full trial is that costs will in-
clude the cost per pregnant woman of group antenatal
care as well as mother and infant primary and secondary
care costs from conception until 4 months postpartum.
As such, in this pilot trial, use of primary and secondary
care will be collected via additional questions on the par-
ticipants’ baseline and follow-up questionnaires. Unit
costs will be obtained from published national sources.
Confidence intervals and cost-effectiveness acceptability
curves will be calculated using bootstrapping (sampling
with replacement). The perspective we will adopt for the
economic evaluation will be health and social care costs.
We will validate our resource use data as part of the
pilot study by checking resource use reported by women
in a sample of questionnaires against medical records.
For the sensitivity analysis, we will use non-parametric
bootstrap to construct confidence intervals for trial data:
one-, two- and multi-way deterministic analyses for any
assumptions made; if a decision model is constructed,
we will do a full probabilistic sensitivity analysis. Trial
missing and censored data will be handled the same way
in the economic evaluation as for the statistical analysis.
Monitoring and auditing
The pilot trial will be overseen by a steering committee.
This group will meet at least once face-to-face during
the 15 months of the pilot trial and then continue to
meet yearly if the main trial goes ahead. This committee
will be responsible for overseeing the pilot and the main
trial, ensuring scientific quality and clinical relevance,
and adherence to ethics and research governance. All
key collaborators on the pilot trial will attend this com-
mittee, as well as a range of experts who are not directly
involved in the pilot, including a chair with relevant ex-
pertise, a statistician, an economist and a PPI member.
The PCTU quality assurance (QA) manager will con-
duct a study risk assessment in collaboration with the
CI. Based on the risk assessment, an appropriate study
monitoring and auditing plan will be produced accord-
ing to PCTU SOPs. This monitoring plan will be
authorised by the sponsor before implementation. The
PCTU QA manager and the sponsor will agree on any
changes to the monitoring plan. The CI will ensure that
safety monitoring and reporting is conducted in accord-
ance with the sponsor’s requirements. This will include
appropriate processes for management of adverse
events.
Patient and public involvement
There has been extensive prior public consultation in
the study area, including interviews and discussion and
stakeholder group meetings. Additional to the feasibil-
ity work already described involving local mothers/
women and the qualitative work with women con-
ducted as part of the programme development grant
[36], the REACH Pregnancy programme has two lay
co-investigators who have contributed to the develop-
ment of the protocol, the participant information
sheets, recruitment methods and data collection instru-
ments, as did members of a patient and public involve-
ment group run by a local women’s health research
network. The City University Research ‘Advisory Group
for Maternal and Child Health Research’ have also been
consulted about potential methods of recruitment. The
lay co-investigators and the patient and public advisory
group will also be invited to contribute to data analysis,
decisions relating to dissemination products and pro-
cesses, review lessons learnt and implications for a fu-
ture trial. The REACH Pregnancy Programme is also a
standard item on the agenda of three local Maternity
Services Liaison Committees’ (MSLCs). Members of
MSLCs include NHS maternity staff and local represen-
tatives of maternity services users.
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Dissemination
The findings of this pilot trial will be presented at na-
tional and international conferences (e.g. Royal Colleges
of Midwives annual conference, the International
Confederation of Midwives Congress and relevant na-
tional public health conferences) and published in peer-
reviewed academic journals. Additionally, findings will
be made available in accessible formats in newsletters
and on the study website, as well as in professional and
practitioner journals. The findings will also be reported
as briefing papers to healthcare commissioners and
managers and to service users via Maternity Service Li-
aison Committees. We will use links with the Repro-
ductive and Childbirth topic network to further
disseminate throughout the NHS.
Discussion
This pilot trial will determine whether a full multi-centre
RCT of Pregnancy Circles can be achieved in an NHS
setting serving populations with high levels of social
deprivation and cultural, linguistic and ethnic diversity
and, if so, the optimum methods for doing so. Our
pre-set progression criteria should be invaluable in sup-
porting key decisions. It will also help to inform the
protocol for a future full trial.
Specific design and methodological decisions that the
pilot trial will also assist with include (a) whether spon-
taneous vaginal birth is the most appropriate primary
outcome measure, and if not, what is a better alternative;
(b) the components of a measure of ‘healthy birth’ for
economic evaluation purposes; and (c) the best source
(either electronic or paper records) of routine maternity
data. It will provide invaluable data about the involve-
ment of women who do not speak English, in terms of
best methods for recruitment and follow-up, the appro-
priateness of using scales validated in English with them
(via bilingual advocates) and for their involvement in
group antenatal care.
If progression to a full trial is supported, using our
pre-determined criteria, the pilot will provide authorita-
tive, high-quality evidence to inform the design and con-
duct of a trial in this important area where it appears
significant potential exists for improvements in health
care and women’s experiences.
Endnotes
1This is the title given by this health service to those
employed to provide language interpreting services.
Additional file
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